Shots:
- This edition explores Digital Vigilance: AI Enhancing Post-Market Safety Monitoring, highlighting how artificial intelligence, real-world data, and digital listening technologies are transforming pharmacovigilance into a proactive, predictive, and patient-centric discipline.
- Through expert perspectives, cover stories, and regulatory insights, we examine the opportunities and challenges of AI-driven safety surveillance—from social media signal detection and real-world evidence generation to governance, transparency, and compliance in the evolving healthcare ecosystem.
- The issue also features The Biopharma Vanguard, spotlighting Robert A. Michael’s leadership at AbbVie; AI Frontiers in Healthcare, showcasing Earendil Labs’ pioneering foundation models for drug discovery; and Product in Focus, highlighting Mounjaro’s role in redefining metabolic disease management through dual-incretin innovation.
